Keyphrases
Clinical Benefit
100%
Antiangiogenic Therapy
100%
Chondrosarcoma
100%
Metastatic Chondrosarcoma
100%
Antiangiogenic Agents
60%
Sarcoma
20%
Anecdotal Evidence
20%
Median Overall Survival
20%
Median Progression-free Survival
20%
Histological Subtypes
20%
Retrospective Data
20%
Referral Center
20%
Clear Cell
20%
Anthracycline-based Chemotherapy
20%
Clear Cell Sarcoma
20%
Substantial Clinical Benefit
20%
Bone Sarcoma
20%
Conventional Cell
20%
Extraskeletal Myxoid Chondrosarcoma
20%
Conventional Chondrosarcoma
20%
Extraskeletal Mesenchymal Chondrosarcoma
20%
Medicine and Dentistry
Chondrosarcoma
100%
Antiangiogenic Therapy
100%
Angiogenesis Inhibitor
33%
Diseases
11%
Overall Survival
11%
Progression Free Survival
11%
Chemotherapy
11%
Anthracycline
11%
Clear Cell
11%
Clear-Cell Sarcoma
11%
Osteosarcoma
11%
Patient Referral
11%
Connective Tissue Cancer
11%
Pharmacology, Toxicology and Pharmaceutical Science
Antiangiogenic Therapy
100%
Chondrosarcoma
100%
Angiogenesis Inhibitor
33%
Chemotherapy
11%
Overall Survival
11%
Progression Free Survival
11%
Osteosarcoma
11%
Clear Cell Sarcoma
11%
Disease
11%
Anthracycline
11%
Connective Tissue Cancer
11%